DN

DNA Group (T.R.) Ltd.

DNA | TA

Overview

Corporate Details

ISIN(s):
IL0011038523
LEI:
Country:
Israel
Address:
Shimon Hatars' 43, 6249245 Tel Aviv
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

DNA Group develops and markets technological solutions for defense and homeland security sectors.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for DNA Group (T.R.) Ltd.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2022-11-06 14:35
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
Hebrew (modern) 149.0 KB
2021-07-29 21:13
Regulatory News Service
Termination of coverage report
Hebrew (modern) 174.5 KB
2021-07-29 21:13
Notice of Dividend Amount
Termination of coverage report
Russian 101.2 KB
2021-06-13 10:10
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
English 1.1 MB
2021-06-13 10:10
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
Russian 101.2 KB
2021-04-11 22:23
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
English 1.1 MB
2021-04-11 22:23
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
Russian 98.1 KB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-12-16 19:22
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-09-01 21:58
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
English 1.1 MB
2020-09-01 21:58
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
Russian 94.7 KB
2020-08-24 21:06
Earnings Release
update analsis (FORST),price target is unchanged
English 1.1 MB
2020-08-24 21:06
Investor Presentation
update analsis (FORST),price target is unchanged
Russian 91.4 KB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
English 1.1 MB
2020-06-10 21:16
Investor Presentation
Quarterly analysis update report
Russian 93.5 KB

Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN